Patent Assignment
Reel/Frame 036662/0053
Security Interest
Recorded: 2015-09-25
Pages: 8
Assignor
THERAKOS, INC.
Executed: 2015-09-25
Assignee
DEUTSCHE BANK AG NEW YORK BRANCH
60 WALL STREET, NEW YORK, NEW YORK, 10005
Covered Properties
(27)
Photopheresis Treatment of Leukocytes
Patent:
5,984,887 →
Application:
08/832,322 →
Method for Removal of Psoralens from Biological Fluids
Patent:
6,228,995 →
Application:
08/835,777 →
Blood Product Irradiation Device Incorporating Agitation
Patent:
5,951,509 →
Application:
08/971,879 →
Apparatus for Pumping Fluid at a Steady Flow Rate
Patent:
5,921,951 →
Application:
08/974,200 →
Integrated Cassette for Controlling Fluid Having an Integral Filter
Patent:
6,491,656 →
Application:
08/975,688 →
Contaminant Detector
Patent:
6,069,687 →
Application:
08/976,386 →
Treatment of Inflammatory Disorders of the Bowel and Urinary Bladder
Patent:
5,985,914 →
Application:
09/111,829 →
Method and System for Determining an Effective Amount of Light Energy to Deliver to Fluids Having Targets for the Light Energy
Patent:
6,219,584 →
Application:
09/350,134 →
Uninterrupted Flow Pump Apparatus and Method
Patent:
6,495,366 →
Application:
09/389,463 →
Low Extracorporeal Volume Treatment System
Patent:
6,793,643 →
Application:
09/556,832 →
Uninterrupted Flow Pump Apparatus and Method
Method and Apparatus for the Continuous Separation of Biological Fluids into Components
Apparatus for the Continuous Separation of Biological Fluids into Components and Method of Using Same
Method for Collecting a Desired Blood Component and Performing a Photopheresis Treatment
Method and Apparatus for Collecting a Blood Component and Performing a Photopheresis Treatment
Phototherapy Compositions and Methods
Apparatus for the Continuous Separation of Biological Fluids into Components and Method of Using Same
Apparatus for the Continuous Separation of Biological Fluids into Components and Method of Using Same
Control System for Driving Fluids Through an Extracorporeal Blood Circuit
Use of Apoptotic Cells Ex Vivo to Generate Regulatory T Cells
Method for Collecting a Desired Blood Component and Performing a Photopheresis Treatment
Uninterrupted Flow Pump Apparatus and Method
Method for Ex-Vivo Expansion of Regulatory T Cells with Enhanced Suppressive Function for Clinical Application in Immune Mediated Diseases
Application:
12/781,451 →
Publication:
US 2010/0291117
Method for Collecting a Desired Blood Component and Performing a Photopheresis Treatment
Phototherapy Compositions and Methods
Uninterrupted Flow Pump Apparatus and Method
Processing Blood
Application:
13/738,039 →
Publication:
US 2014/0030238
Related Assignments
(25)
Other recorded transfers of the patents in this record — the chain of ownership.
Release of Security Interest in Intellectual Property Collateral at Reel/Frame No. 29549/0074
Sep 25, 2015
From: ROYAL BANK OF CANADA
To: THERAKOS, INC.
Reel/Frame 036688/0833 →
Release of Security Interest in Intellectual Property Collateral at Reel/Frame No. 29549/0119
Sep 25, 2015
From: ROYAL BANK OF CANADA
To: THERAKOS, INC.
Reel/Frame 036688/0863 →
Corrective Assignment to Correct the Execution Date Previously Recorded at Reel: 036868 Frame: 0084. Assignor(S) Hereby Confirms the Change of Name.
Nov 23, 2015
From: SONY ERICSSON MOBILE COMMUNICATIONS AB
To: SONY MOBILE COMMUNICATIONS AB
Reel/Frame 037207/0572 →
Assignment of Assignor's Interest
Mar 5, 2016
From: MALLINCKRODT IP
To: MALLINCKRODT HOSPITAL PRODUCTS IP LIMITED
Reel/Frame 038009/0016 →
Assignment of Assignor's Interest
Mar 5, 2016
From: THERAKOS, INC.
To: MALLINCKRODT CRITICAL CARE FINANCE INC.
Reel/Frame 038008/0824 →
Assignment of Assignor's Interest
Mar 5, 2016
From: MALLINCKRODT CRITICAL CARE FINANCE INC.
To: MALLINCKRODT PHARMA IP TRADING DAC
Reel/Frame 038038/0009 →
Assignment of Assignor's Interest
Mar 5, 2016
From: MALLINCKRODT PHARMA IP TRADING DAC
To: MALLINCKRODT IP
Reel/Frame 038009/0058 →
Nunc Pro Tunc Assignment
Jul 1, 2019
From: THERAKOS, INC.
To: MALLINCKRODT CRITICAL CARE FINANCE INC.
Reel/Frame 049643/0168 →
Nunc Pro Tunc Assignment
Jul 1, 2019
From: MALLINCKRODT IP
To: MALLINCKRODT HOSPITAL PRODUCTS IP LIMITED
Reel/Frame 049643/0397 →
Nunc Pro Tunc Assignment
Jul 1, 2019
From: MALLINCKRODT PHARMA IP TRADING D.A.C.
To: MALLINCKRODT IP
Reel/Frame 049643/0348 →
Nunc Pro Tunc Assignment
Jul 1, 2019
From: MALLINCKRODT CRITICAL CARE FINANCE INC.
To: MALLINCKRODT PHARMA IP TRADING D.A.C.
Reel/Frame 049643/0282 →
Notice of Grant of Security Interest in Intellectual Property
Jul 22, 2019
From: MALLINCKRODT HOSPITAL PRODUCTS IP LIMITED
To: DEUTSCHE BANK AG NEW YORK BRANCH, AS COLLATERAL AGENT
Reel/Frame 049822/0674 →
Security Interest
Dec 10, 2019
From: MALLINCKRODT ARD IP LIMITED; MALLINCKRODT HOSPITAL PRODUCTS IP LIMITED; SPECGX LLC; OCERA THERAPEUTICS, INC.
To: WILMINGTON SAVINGS FUND SOCIETY, FSB, AS SECOND LIEN COLLATERAL AGENT
Reel/Frame 051256/0829 →
Security Interest
Jun 17, 2022
From: MALLINCKRODT ENTERPRISES LLC; MALLINCKRODT LLC; SPECGX LLC; OCERA THERAPEUTICS, INC.
To: WILMINGTON SAVINGS FUND SOCIETY, FSB, AS SECOND LIEN COLLATERAL AGENT
Reel/Frame 060389/0913 →
Release of Security Interest
Jun 17, 2022
From: WILMINGTON SAVINGS FUND SOCIETY, FSB, AS SECOND LIEN COLLATERAL AGENT
To: OCERA THERAPEUTICS, INC.; MALLINCKRODT LLC; MALLINCKRODT ARD IP UNLIMITED COMPANY (F/K/A MALLINCKRODT ARD IP LIMITED); MALLINCKRODT HOSPITAL PRODUCTS IP UNLIMITED COMPANY (F/K/A MALLINCKRODT HOSPITAL PRODUCTS IP LIMITED)
Reel/Frame 060389/0839 →
Notice of Grant of Security Interest in Intellectual Property
Jun 22, 2022
From: MALLINCKRODT ENTERPRISES LLC; MALLINCKRODT LLC; SPECGX LLC; OCERA THERAPEUTICS, INC.
To: DEUTSCHE BANK AG NEW YORK BRANCH
Reel/Frame 060434/0536 →
Release of Security Interests in Patents at Reel 060389/Frame 0913
Nov 15, 2023
From: WILMINGTON SAVINGS FUND SOCIETY, FSB, AS SECOND LIEN COLLATERAL AGENT
To: OCERA THERAPEUTICS LLC (F/K/A OCERA THERAPEUTICS, INC.); MALLINCKRODT LLC; MALLINCKRODT ENTERPRISES LLC; MALLINCKRODT PHARMA IP TRADING UNLIMITED COMPANY
Reel/Frame 065583/0465 →
Security Interest
Nov 15, 2023
From: MALLINCKRODT ENTERPRISES LLC; MALLINCKRODT LLC; MALLINCKRODT PHARMA IP TRADING UNLIMITED COMPANY; MALLINCKRODT PHARMACEUTICALS IRELAND LIMITED
To: ACQUIOM AGENCY SERVICES LLC
Reel/Frame 065595/0376 →
Release of Patent Security Interests Recorded at Reel 036662, Frame 0053
Nov 16, 2023
From: DEUTSCHE BANK AG NEW YORK BRANCH, AS COLLATERAL AGENT
To: MALLINCKRODT INTERNATIONAL FINANCE S.A.; MALLINCKRODT CB LLC; MALLINCKRODT FINANCE GMBH; MALLINCKRODT US HOLDINGS LLC (F/K/A MALLINCKRODT US HOLDINGS INC.)
Reel/Frame 065610/0503 →
Release of Patent Security Interests Recorded at Reel 049822, Frame 0674
Nov 16, 2023
From: DEUTSCHE BANK AG NEW YORK BRANCH, AS COLLATERAL AGENT
To: MALLINCKRODT INTERNATIONAL FINANCE S.A.; MALLINCKRODT CB LLC; MALLINCKRODT FINANCE GMBH; MALLINCKRODT US HOLDINGS LLC (F/K/A MALLINCKRODT US HOLDINGS INC.)
Reel/Frame 065609/0454 →
Release of Patent Security Interests Recorded at Reel 060434, Frame 0536
Nov 16, 2023
From: DEUTSCHE BANK AG NEW YORK BRANCH, AS COLLATERAL AGENT
To: MALLINCKRODT ENTERPRISES LLC; MALLINCKRODT LLC; SPECGX LLC; OCERA THERAPEUTICS, INC.
Reel/Frame 065601/0347 →
Change of Name
Nov 4, 2024
From: MALLINCKRODT HOSPITAL PRODUCTS IP LIMITED
To: MALLINCKRODT HOSPITAL PRODUCTS IP UNLIMITED COMPANY
Reel/Frame 069301/0664 →
Assignment of Assignor's Interest
Nov 4, 2024
From: MALLINCKRODT HOSPITAL PRODUCTS IP UNLIMITED COMPANY
To: MALLINCKRODT PHARMACEUTICALS IRELAND LIMITED
Reel/Frame 069127/0749 →
Patent Security Agreement
Dec 3, 2024
From: SOLARIS IPCO LIMITED
To: NOMURA CORPORATION FUNDING AMERICAS, LLC, AS ADMINISTRATIVE AGENT AND COLLATERAL AGENT
Reel/Frame 069476/0380 →
Release of Security Interests
Dec 3, 2024
From: ACQUIOM AGENCY SERVICES, LLC, AS COLLATERAL AGENT
To: MALLINCKRODT PHARMA IP TRADING LIMITED; STRATATECH CORPORATION; MALLINCKRODT PHARMACEUTICALS IRELAND LIMITED
Reel/Frame 069476/0103 →